Ana Martín‐Suárez

596 total citations
29 papers, 444 citations indexed

About

Ana Martín‐Suárez is a scholar working on Pharmacology, Epidemiology and Human-Computer Interaction. According to data from OpenAlex, Ana Martín‐Suárez has authored 29 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Epidemiology and 6 papers in Human-Computer Interaction. Recurrent topics in Ana Martín‐Suárez's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Virtual Reality Applications and Impacts (6 papers) and Pneumonia and Respiratory Infections (5 papers). Ana Martín‐Suárez is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Virtual Reality Applications and Impacts (6 papers) and Pneumonia and Respiratory Infections (5 papers). Ana Martín‐Suárez collaborates with scholars based in Spain, United States and Portugal. Ana Martín‐Suárez's co-authors include María Victoria Martínez Calvo, Maria Gatta, José M. Lanao, Hinojal Zazo Gómez, Fernándo Muñoz, Cristina Maderuelo, Juan Cruz-Benito, Francisco José García‐Peñalvo, Alfonso Domínguez‐Gil and Cándido Martín Luengo and has published in prestigious journals such as Scientific Reports, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Ana Martín‐Suárez

26 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Martín‐Suárez Spain 13 195 121 111 60 56 29 444
Susan Raber United States 14 283 1.5× 132 1.1× 168 1.5× 58 1.0× 51 0.9× 33 628
Hidefumi Kasai Japan 12 145 0.7× 154 1.3× 56 0.5× 32 0.5× 54 1.0× 37 350
Yuki Hanai Japan 11 179 0.9× 247 2.0× 112 1.0× 14 0.2× 100 1.8× 34 384
Julie Passarell United States 14 526 2.7× 253 2.1× 285 2.6× 48 0.8× 141 2.5× 38 909
Mika Ishihara Japan 13 197 1.0× 243 2.0× 81 0.7× 14 0.2× 130 2.3× 24 447
Chika Ogami Japan 10 156 0.8× 165 1.4× 46 0.4× 17 0.3× 69 1.2× 18 306
Marina Kostić Serbia 10 42 0.2× 65 0.5× 59 0.5× 25 0.4× 23 0.4× 42 329
G KEARNS United States 10 75 0.4× 72 0.6× 51 0.5× 97 1.6× 30 0.5× 22 392
William Knebel United States 11 233 1.2× 280 2.3× 161 1.5× 49 0.8× 58 1.0× 20 504
Simona Iftimie Spain 13 45 0.2× 153 1.3× 99 0.9× 22 0.4× 132 2.4× 38 435

Countries citing papers authored by Ana Martín‐Suárez

Since Specialization
Citations

This map shows the geographic impact of Ana Martín‐Suárez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martín‐Suárez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martín‐Suárez more than expected).

Fields of papers citing papers by Ana Martín‐Suárez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Martín‐Suárez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martín‐Suárez. The network helps show where Ana Martín‐Suárez may publish in the future.

Co-authorship network of co-authors of Ana Martín‐Suárez

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Martín‐Suárez. A scholar is included among the top collaborators of Ana Martín‐Suárez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Martín‐Suárez. Ana Martín‐Suárez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jesus, Ângelo, et al.. (2025). Adverse Reactions by Radiopharmaceuticals: Retrospective Analysis of the Portuguese National Pharmacovigilance System. Annals of Pharmacotherapy. 59(10). 919–927.
2.
Martín‐Suárez, Ana, et al.. (2023). Medication delivery errors in outpatients with percutaneous endoscopic gastrostomy: effect on tube feeding replacement. Scientific Reports. 13(1). 21727–21727.
3.
Gómez, Hinojal Zazo, et al.. (2022). Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK. Frontiers in Pharmacology. 13. 977372–977372. 13 indexed citations
4.
Martín‐Suárez, Ana, et al.. (2021). Compliance with antibiotic prophylaxis guidelines in caesarean delivery: a retrospective, drug utilization study (indication-prescription type) at an Ecuadorian hospital. Antimicrobial Resistance and Infection Control. 10(1). 12–12. 8 indexed citations
5.
Fernández, Eva María Sáez, et al.. (2021). Evaluation of Current Amikacin Dosing Recommendations and Development of an Interactive Nomogram: The Role of Albumin. Pharmaceutics. 13(2). 264–264. 9 indexed citations
6.
Colin, Pieter, Karel Allegaert, Alison H. Thomson, et al.. (2019). Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations. Clinical Pharmacokinetics. 58(6). 767–780. 67 indexed citations
7.
Fernández, Eva María Sáez, et al.. (2019). Evaluation of renal function equations to predict amikacin clearance. Expert Review of Clinical Pharmacology. 12(8). 805–813. 8 indexed citations
8.
Muñoz, Fernándo, et al.. (2018). Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 56(1). 28–41. 14 indexed citations
9.
Martín‐Suárez, Ana, et al.. (2016). A New Method for Individualized Digoxin Dosing in Elderly Patients. Drugs & Aging. 33(4). 277–284. 1 indexed citations
10.
Cruz-Benito, Juan, Cristina Maderuelo, Francisco José García‐Peñalvo, et al.. (2016). Usalpharma: A Software Architecture to Support Learning in Virtual Worlds. IEEE Revista Iberoamericana de Tecnologias del Aprendizaje. 11(3). 194–204. 5 indexed citations
11.
Martín‐Suárez, Ana, et al.. (2015). Usalpharma: Una arquitectura software al servicio del aprendizaje en Mundos Virtuales. 2 indexed citations
12.
García‐Peñalvo, Francisco José, et al.. (2014). Usalpharma: A Cloud-Based Architecture to Support Quality Assurance Training Processes in Health Area Using Virtual Worlds. The Scientific World JOURNAL. 2014. 1–10. 20 indexed citations
13.
Gómez, Hinojal Zazo, Ana Martín‐Suárez, & José M. Lanao. (2013). Evaluating amikacin dosage regimens in intensive care unit patients: A pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. International Journal of Antimicrobial Agents. 42(2). 155–160. 19 indexed citations
14.
Martín‐Suárez, Ana, et al.. (2013). Approaches for dosage individualisation in critically ill patients. Expert Opinion on Drug Metabolism & Toxicology. 9(11). 1481–1493. 13 indexed citations
15.
Martín‐Suárez, Ana, et al.. (2010). Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. British Journal of Clinical Pharmacology. 70(2). 201–212. 111 indexed citations
16.
Calvo, María Victoria Martínez, et al.. (2010). Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma. Clinical Biochemistry. 44(2-3). 260–263. 17 indexed citations
17.
Cobo, Ana María, et al.. (2010). Clinical Repercussions of Analytical Interferences Due to Aldosterone Antagonists in Digoxin Immunoassays: An Assessment. Therapeutic Drug Monitoring. 32(2). 169–176. 3 indexed citations
18.
Calvo, R., et al.. (2004). Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients. Acta Anaesthesiologica Scandinavica. 48(8). 1038–1048. 14 indexed citations
19.
Martín‐Suárez, Ana, et al.. (2002). Population Pharmacokinetics of Digoxin in Pediatric Patients. Therapeutic Drug Monitoring. 24(6). 742–745. 9 indexed citations
20.
Martín‐Suárez, Ana, et al.. (1993). Digoxin pharmacokinetics in patients with high serum digoxin concentrations. Journal of Clinical Pharmacy and Therapeutics. 18(1). 63–68. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Raber Breakdown of academic impact, for papers by Hidefumi Kasai Breakdown of academic impact, for papers by Yuki Hanai Breakdown of academic impact, for papers by Julie Passarell Breakdown of academic impact, for papers by Mika Ishihara Breakdown of academic impact, for papers by Chika Ogami Breakdown of academic impact, for papers by Marina Kostić Breakdown of academic impact, for papers by G KEARNS Breakdown of academic impact, for papers by William Knebel Breakdown of academic impact, for papers by Simona Iftimie
Rankless by CCL
2026